XML 17 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
At The Market Offering
Common Stock
At The Market Offering
Additional Paid-in Capital
At The Market Offering
Equity Line Financing
Common Stock
Equity Line Financing
Additional Paid-in Capital
Equity Line Financing
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Beginning Balances at Dec. 31, 2021             $ 22 $ 145,453 $ (94,004) $ (198) $ 51,273
Beginning Balances (in shares) at Dec. 31, 2021             22,230,032        
Shareholders' Equity                      
Exercise of common stock options               303     $ 303
Exercise of common stock options (in shares)             348,552       348,552
Equity-based compensation               1,001     $ 1,001
Other comprehensive gain                   1 1
Net loss                 (3,838)   (3,838)
Ending Balances at Mar. 31, 2022             $ 22 146,757 (97,842) (197) 48,740
Ending Balances (in shares) at Mar. 31, 2022             22,578,584        
Beginning Balances at Dec. 31, 2022             $ 29 155,820 (115,401) (199) $ 40,249
Beginning Balances (in shares) at Dec. 31, 2022             28,991,548        
Shareholders' Equity                      
Exercise of common stock options (in shares)                     0
Equity-based compensation               1,187     $ 1,187
Value of shares issued   $ 197 $ 197   $ 318 $ 318          
Shares issued 95,823     189,856              
Other comprehensive gain                   4 4
Net loss                 (6,172)   (6,172)
Ending Balances at Mar. 31, 2023             $ 29 $ 157,522 $ (121,573) $ (195) $ 35,783
Ending Balances (in shares) at Mar. 31, 2023             29,277,227